Pharmaceutical Information |
Drug Name |
Amobarbital |
Drug ID |
BADD_D00126 |
Description |
A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565) |
Indications and Usage |
Not Available |
Marketing Status |
approved; illicit |
ATC Code |
N05CA02 |
DrugBank ID |
DB01351
|
KEGG ID |
D00555
|
MeSH ID |
D000654
|
PubChem ID |
2164
|
TTD Drug ID |
D0R6BR
|
NDC Product Code |
Not Available |
UNII |
GWH6IJ239E
|
Synonyms |
Amobarbital | Amylobarbitone | Placidel | Amobarbital Sodium | Sodium, Amobarbital | Sodium Amobarbital | Amobarbital, Sodium | Amsal | Amylbarb sodium | Amylobeta | Amytal | Amytal Sodium | Sodium Amytal | Barbamyl | Eunoctal | Isoamitil Sedante | Isonal | Neur-Amyl | Novamobarb | Pentymal | Transital |
|
Chemical Information |
Molecular Formula |
C11H18N2O3 |
CAS Registry Number |
57-43-2 |
SMILES |
CCC1(C(=O)NC(=O)NC1=O)CCC(C)C |
Chemical Structure |
|
|
ADRs Induced by Drug |
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|